• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前促肾上腺皮质激素水平可预测库欣病的复发。

Adrenocorticotropic hormone levels before treatment predict recurrence of Cushing's disease.

作者信息

Kuo Chun-Heng, Shih Shyang-Rong, Li Hung-Yuan, Chen Szu-Chi, Hung Po-Ju, Tseng Fen-Yu, Chang Tien-Chun

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; New Taipei City Hospital, New Taipei City, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; National Taiwan University College of Medicine, Taipei, Taiwan; Center of Anti-aging and Health Consultation, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

J Formos Med Assoc. 2017 Jun;116(6):441-447. doi: 10.1016/j.jfma.2016.08.008. Epub 2016 Oct 28.

DOI:10.1016/j.jfma.2016.08.008
PMID:28029519
Abstract

BACKGROUND/PURPOSE: Cushing's disease (CD) is the most common cause of endogenous Cushing's syndrome. Transsphenoidal surgery (TSS) is the first choice of treatment. Predicting prognosis after treatment can benefit further strategies of management, but currently there is no convenient predictor. This study aims to investigate characteristic changes after treatment and to identify potential prognostic predictors.

METHODS

We retrospectively studied the records of CD patients presenting to the National Taiwan University Hospital, Taipei, Taiwan between 1992 and 2011. They were categorized according to treatment response. Clinical features and examination findings were compared between groups.

RESULTS

Forty-one patients with CD were included. The follow-up time was 0.26-19.3 years. The time interval between the onset of symptoms and diagnosis was 2.1-120.0 months. The initial remission rate of CD after the first treatment was 82.9%. Mean body mass index (BMI) was 27.4 kg/m before treatment and 26.0 kg/m 3 months after treatment. The patients in remission had a greater decrease in BMI after treatment and lower dehydroepiandrosterone sulfate (DHEAS) levels before treatment, compared with the recurrent group (both p < 0.05). Adrenocorticotropic hormone (ACTH) levels before treatment showed a significant positive correlation with recurrent diseases (p < 0.05).

CONCLUSION

A larger decrease in BMI after treatment and lower DHEAS levels before treatment were noted for the patients who stayed in CD remission. Higher ACTH levels before treatment predicted a recurrence of CD. These are potentially simple and practical predictors of prognosis.

摘要

背景/目的:库欣病(CD)是内源性库欣综合征最常见的病因。经蝶窦手术(TSS)是首选的治疗方法。预测治疗后的预后有助于进一步的管理策略,但目前尚无便捷的预测指标。本研究旨在探讨治疗后的特征性变化,并确定潜在的预后预测指标。

方法

我们回顾性研究了1992年至2011年间就诊于台湾台北国立台湾大学医院的CD患者的记录。根据治疗反应对他们进行分类。比较各组之间的临床特征和检查结果。

结果

纳入41例CD患者。随访时间为0.26 - 19.3年。症状出现与诊断之间的时间间隔为2.1 - 120.0个月。首次治疗后CD的初始缓解率为82.9%。治疗前平均体重指数(BMI)为27.4kg/m²,治疗后3个月为26.0kg/m²。与复发组相比,缓解组患者治疗后BMI下降幅度更大,治疗前硫酸脱氢表雄酮(DHEAS)水平更低(均p < 0.05)。治疗前促肾上腺皮质激素(ACTH)水平与复发疾病呈显著正相关(p < 0.05)。

结论

CD缓解的患者治疗后BMI下降幅度更大,治疗前DHEAS水平更低。治疗前ACTH水平较高预示着CD会复发。这些是潜在的简单实用的预后预测指标。

相似文献

1
Adrenocorticotropic hormone levels before treatment predict recurrence of Cushing's disease.治疗前促肾上腺皮质激素水平可预测库欣病的复发。
J Formos Med Assoc. 2017 Jun;116(6):441-447. doi: 10.1016/j.jfma.2016.08.008. Epub 2016 Oct 28.
2
Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.库欣病和无功能促肾上腺皮质激素腺瘤患者经蝶窦手术后的并发症。
Neurosurg Focus. 2015 Feb;38(2):E12. doi: 10.3171/2014.10.FOCUS14705.
3
Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.术后早期促肾上腺皮质激素(ACTH)和皮质醇作为库欣病缓解的预测指标
Acta Neurochir (Wien). 2007;149(5):471-7; discussion 477-9. doi: 10.1007/s00701-007-1133-1. Epub 2007 Apr 5.
4
Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.复发性库欣病再次经蝶窦手术的术后结果。
Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.
5
Predictive factors for the recurrence of Cushing's disease after surgical treatment in childhood.儿童手术后库欣病复发的预测因素。
Endokrynol Pol. 2020;71(4):313-318. doi: 10.5603/EP.a2020.0026.
6
Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up.库欣病经蝶窦重复手术的结果。长期随访。
Endocrinol Nutr. 2014 Apr;61(4):176-83. doi: 10.1016/j.endonu.2013.10.008. Epub 2013 Dec 17.
7
DHEA(S)--a novel marker in Cushing's disease.脱氢表雄酮(DHEA(S))——库欣病的一个新标志物。
Acta Neurochir (Wien). 2013 Mar;155(3):479-84; discussion 484. doi: 10.1007/s00701-012-1596-6. Epub 2013 Jan 13.
8
Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.库欣病的管理:垂体磁共振成像检测到微腺瘤患者的结局
J Neurosurg. 2008 Oct;109(4):751-9. doi: 10.3171/JNS/2008/109/10/0751.
9
Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison.使用皮质醇、去氨加压素及联合地塞米松-去氨加压素试验对库欣病进行术后随访:一项直接比较
Clin Endocrinol (Oxf). 2015 Aug;83(2):216-22. doi: 10.1111/cen.12739. Epub 2015 Mar 20.
10
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.联合生化检测在垂体磁共振成像阴性的库欣病诊断中的应用价值
Eur J Endocrinol. 2007 Feb;156(2):241-8. doi: 10.1530/eje.1.02332.

引用本文的文献

1
The CuPeR model: A dynamic online tool for predicting Cushing's disease persistence and recurrence after pituitary surgery.CuPeR模型:一种用于预测垂体手术后库欣病持续存在和复发的动态在线工具。
J Clin Transl Endocrinol. 2025 Aug 27;41:100417. doi: 10.1016/j.jcte.2025.100417. eCollection 2025 Sep.
2
Predictive factors for recurrence of Cushing's disease after pituitary surgery.垂体手术后库欣病复发的预测因素。
Tunis Med. 2022;100(12):843-846.
3
Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing's disease.
术后早期血清皮质醇最低点虽低但并非不可检测,可预测库欣病的持续缓解。
Endocr Oncol. 2022 Apr 7;2(1):19-31. doi: 10.1530/EO-21-0026. eCollection 2022 Jan.
4
Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment.成人库欣病垂体手术后的复发:关于诊断和治疗的系统评价
Endocrine. 2020 Nov;70(2):218-231. doi: 10.1007/s12020-020-02432-z. Epub 2020 Aug 2.
5
Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge.库欣病中高皮质醇血症的复发:一项诊断挑战。
Front Endocrinol (Lausanne). 2019 Nov 8;10:740. doi: 10.3389/fendo.2019.00740. eCollection 2019.
6
Treatment challenges in pediatric Cushing's disease: Review of the literature with particular emphasis on predictive factors for the disease recurrence.儿科库欣病的治疗挑战:文献综述,特别强调疾病复发的预测因素。
Endocrine. 2019 Nov;66(2):125-136. doi: 10.1007/s12020-019-02036-2. Epub 2019 Nov 7.
7
Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas.根据促肾上腺皮质激素腺瘤细胞标志物的表达判断其激素侵袭性。
Endocrine. 2019 Apr;64(1):147-156. doi: 10.1007/s12020-018-1815-x. Epub 2018 Nov 24.
8
The experience with transsphenoidal surgery and its importance to outcomes.经蝶窦手术的经验及其对结果的重要性。
Pituitary. 2018 Oct;21(5):545-555. doi: 10.1007/s11102-018-0904-4.
9
The Utility of Preoperative ACTH/Cortisol Ratio for the Diagnosis and Prognosis of Cushing's Disease.术前促肾上腺皮质激素/皮质醇比值在库欣病诊断和预后评估中的应用
J Neurosci Rural Pract. 2018 Jan-Mar;9(1):106-111. doi: 10.4103/jnrp.jnrp_308_17.